What is the recommended treatment for bacterial conjunctivitis during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Bacterial Conjunctivitis in Pregnancy

For bacterial conjunctivitis in pregnancy, use topical ophthalmic antibiotics as first-line therapy, reserving systemic antibiotics specifically for gonococcal or chlamydial conjunctivitis where azithromycin 1g orally as a single dose or amoxicillin 500mg three times daily for 7 days are the recommended options. 1

Topical Therapy for Uncomplicated Bacterial Conjunctivitis

For typical bacterial conjunctivitis (caused by Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis), topical ophthalmic antibiotics are safe and effective during pregnancy. A 2022 propensity-score matched study of 891 pregnant women found no association between first-trimester exposure to topical ophthalmic antibiotics (including fluoroquinolones) and adverse neonatal outcomes including congenital anomalies, preterm birth, or low birth weight 2. This provides reassuring safety data for topical therapy.

Topical azithromycin 1% ophthalmic preparation is particularly effective, with high clinical cure rates and minimal adverse effects 3. Other topical antibiotic options include erythromycin ointment or polymyxin B-trimethoprim drops.

Systemic Therapy for Gonococcal and Chlamydial Conjunctivitis

When gonococcal or chlamydial conjunctivitis is suspected or confirmed, systemic antibiotics are mandatory due to risk of severe complications and systemic infection 1, 4:

For Chlamydial Conjunctivitis:

  • Azithromycin 1g orally as a single dose (preferred)
  • Amoxicillin 500mg orally three times daily for 7 days (alternative)
  • Erythromycin base or ethylsuccinate is also acceptable

Critical Contraindications:

Pregnant women must NOT receive doxycycline, quinolones (including oral fluoroquinolones), or tetracyclines 1. While topical fluoroquinolones appear safe 2, systemic fluoroquinolones are contraindicated.

Clinical Decision Algorithm

  1. Assess presentation: Mucopurulent discharge with matted eyelids suggests bacterial etiology 5

  2. Identify high-risk features requiring systemic therapy:

    • Sexual history suggesting gonococcal/chlamydial exposure
    • Severe purulent discharge
    • Preauricular lymphadenopathy
    • Lack of response to topical therapy
  3. For typical bacterial conjunctivitis: Start topical antibiotics (azithromycin 1%, erythromycin, or polymyxin B-trimethoprim)

  4. For suspected gonococcal/chlamydial infection: Add systemic azithromycin 1g single dose or amoxicillin 500mg three times daily for 7 days

  5. If persistent after 3-5 days: Obtain cultures and consider gonococcal/chlamydial testing

Important Caveats

The distinction between viral and bacterial conjunctivitis cannot be made reliably on clinical grounds alone 5. However, bacterial conjunctivitis more commonly presents with mucopurulent discharge and matted eyelids, particularly in the morning.

Maternal screening and treatment during pregnancy effectively reduces perinatal transmission of gonococcal and chlamydial infections to neonates 4, 6. A 2017 trial demonstrated that azithromycin given to women in labor reduced bacterial neonatal conjunctivitis, particularly gram-positive infections 6.

Strict hand hygiene is essential to prevent transmission, as bacterial conjunctivitis is highly contagious 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.